New drug shows promise for Long-Term control of rare hormone disorder
NCT ID NCT06531941
First seen Nov 01, 2025 · Last updated May 07, 2026 · Updated 21 times
Summary
This study looks at the long-term safety of a weekly injection called MBX 2109 for people with hypoparathyroidism, a condition where the body doesn't produce enough parathyroid hormone. Participants are adults who already completed a 12-week treatment in an earlier study. The goal is to see if the drug is safe and tolerable over a longer period.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HYPOPARATHYROIDISM are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
MBX Biosciences Investigational Site
Miami, Florida, 33033, United States
-
MBX Biosciences Investigational Site
Macon, Georgia, 31210, United States
-
MBX Biosciences Investigational Site
Jackson, Mississippi, 39202, United States
-
MBX Biosciences Investigational Site
St Louis, Missouri, 63110, United States
-
MBX Biosciences Investigational Site
Las Vegas, Nevada, 89148, United States
-
MBX Biosciences Investigational Site
Reno, Nevada, 89511, United States
-
MBX Biosciences Investigational Site
Albany, New York, 12203, United States
-
MBX Biosciences Investigational Site
New York, New York, 10032, United States
-
MBX Biosciences Investigational Site
The Bronx, New York, 10467, United States
-
MBX Biosciences Investigational Site
Columbus, Ohio, 43201, United States
-
MBX Biosciences Investigational Site
Dallas, Texas, 75208, United States
-
MBX Biosciences Investigational Site
El Paso, Texas, 79935, United States
-
MBX Biosciences Investigational Site
Fort Worth, Texas, 76132, United States
-
MBX Biosciences Investigational Site
Round Rock, Texas, 78681, United States
-
MBX Biosciences Investigational Site
San Antonio, Texas, 78231, United States
-
MBX Biosciences Investigational Site
Weslaco, Texas, 78596, United States
-
MBX Biosciences Investigational Site
Madison, Wisconsin, 53705, United States
-
MBX Biosciences Investigational Site
Ciudad Autonoma de Buenos Aires, Buenos Aires, C1012AAR, Argentina
-
MBX Biosciences Investigational Site
Ciudad Autonoma de Buenos Aires, Buenos Aires, C1425AGC, Argentina
-
MBX Biosciences Investigational Site
Córdoba, Río Cuarto, X5800AEV, Argentina
-
MBX Biosciences Investigational Site
Córdoba, X5000AAW, Argentina
-
MBX Biosciences Investigational Site
San Miguel de Tucumán, T4000IEH, Argentina
-
MBX Biosciences Investigational Site
Samsun, 55270, Turkey (Türkiye)
Conditions
Explore the condition pages connected to this study.